TY - JOUR
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adulthood (18 yrs & older)
KW - article
KW - Australia
KW - buprenorphine
KW - cost effectiveness
KW - Depression, Anxiety and Stress Scales--21
KW - Drug Dependency
KW - drug effectiveness
KW - Drug Rehabilitation
KW - Drug Therapy
KW - Empirical Study
KW - Female
KW - Followup Study
KW - Health Care Costs
KW - Heroin Addiction
KW - heroin dependence
KW - Human
KW - Male
KW - naloxone
KW - Opiate Treatment Index-Drug Use Scale
KW - Outpatient
KW - Quantitative Study
KW - Treatment Effectiveness Evaluation
KW - Treatment Outcome/Clinical Trial
KW - WHO Quality of life BREF Inventory
AU - James Bell
AU - Marian Shanahan
AU - Carolyn Mutch
AU - Felicity Rea
AU - Anni Ryan
AU - Robert Batey
AU - Adrian Dunlop
AU - Adam Winstock
A1 - 
BT - Addiction
C5 - Opioids & Substance Use; Financing & Sustainability
CP - 12
IS - 12
JF - Addiction
PB - Wiley-Blackwell Publishing Ltd. Blackwell Publishing
PY - 2007
SN - 0965-2140, 0965-2140
SP - 1899
EP - 1907
EP - 
T1 - A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
T2 - Addiction
TI - A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
U1 - Opioids & Substance Use; Financing & Sustainability
VL - 102
VO - 0965-2140, 0965-2140
Y1 - 2007
ER -